BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 21626678)

  • 1. 5q14.3 neurocutaneous syndrome: a novel continguous gene syndrome caused by simultaneous deletion of RASA1 and MEF2C.
    Carr CW; Zimmerman HH; Martin CL; Vikkula M; Byrd AC; Abdul-Rahman OA
    Am J Med Genet A; 2011 Jul; 155A(7):1640-5. PubMed ID: 21626678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 5q14.3 deletion neurocutaneous syndrome: Contiguous gene syndrome caused by simultaneous deletion of RASA1 and MEF2C: A progressive disease.
    Ilari R; Agosta G; Bacino C
    Am J Med Genet A; 2016 Mar; 170(3):688-93. PubMed ID: 26774077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe mental retardation, seizures, and hypotonia due to deletions of MEF2C.
    Nowakowska BA; Obersztyn E; Szymańska K; Bekiesińska-Figatowska M; Xia Z; Ricks CB; Bocian E; Stockton DW; Szczałuba K; Nawara M; Patel A; Scott DA; Cheung SW; Bohan TP; Stankiewicz P
    Am J Med Genet B Neuropsychiatr Genet; 2010 Jul; 153B(5):1042-51. PubMed ID: 20333642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MEF2C haploinsufficiency caused by either microdeletion of the 5q14.3 region or mutation is responsible for severe mental retardation with stereotypic movements, epilepsy and/or cerebral malformations.
    Le Meur N; Holder-Espinasse M; Jaillard S; Goldenberg A; Joriot S; Amati-Bonneau P; Guichet A; Barth M; Charollais A; Journel H; Auvin S; Boucher C; Kerckaert JP; David V; Manouvrier-Hanu S; Saugier-Veber P; Frébourg T; Dubourg C; Andrieux J; Bonneau D
    J Med Genet; 2010 Jan; 47(1):22-9. PubMed ID: 19592390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5q14.3 Microdeletions: A Contiguous Gene Syndrome with Capillary Malformation-Arteriovenous Malformation Syndrome and Neurologic Findings.
    Park SM; Kim JM; Kim GW; Kim HS; Kim BS; Kim MB; Ko HC
    Pediatr Dermatol; 2017 Mar; 34(2):156-159. PubMed ID: 28297145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interstitial deletion 5q14.3q21.3 with MEF2C haploinsufficiency and mild phenotype: when more is less.
    Tonk V; Kyhm JH; Gibson CE; Wilson GN
    Am J Med Genet A; 2011 Jun; 155A(6):1437-41. PubMed ID: 21567930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations in MEF2C from the 5q14.3q15 microdeletion syndrome region are a frequent cause of severe mental retardation and diminish MECP2 and CDKL5 expression.
    Zweier M; Gregor A; Zweier C; Engels H; Sticht H; Wohlleber E; Bijlsma EK; Holder SE; Zenker M; Rossier E; Grasshoff U; Johnson DS; Robertson L; Firth HV; ; Ekici AB; Reis A; Rauch A
    Hum Mutat; 2010 Jun; 31(6):722-33. PubMed ID: 20513142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. De novo microdeletion of 5q14.3 excluding MEF2C in a patient with infantile spasms, microcephaly, and agenesis of the corpus callosum.
    Shimojima K; Okumura A; Mori H; Abe S; Ikeno M; Shimizu T; Yamamoto T
    Am J Med Genet A; 2012 Sep; 158A(9):2272-6. PubMed ID: 22848023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. De novo 5q14.3 translocation 121.5-kb upstream of MEF2C in a patient with severe intellectual disability and early-onset epileptic encephalopathy.
    Saitsu H; Igarashi N; Kato M; Okada I; Kosho T; Shimokawa O; Sasaki Y; Nishiyama K; Tsurusaki Y; Doi H; Miyake N; Harada N; Hayasaka K; Matasumoto N
    Am J Med Genet A; 2011 Nov; 155A(11):2879-84. PubMed ID: 21990267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Refining the phenotype associated with MEF2C haploinsufficiency.
    Novara F; Beri S; Giorda R; Ortibus E; Nageshappa S; Darra F; Dalla Bernardina B; Zuffardi O; Van Esch H
    Clin Genet; 2010 Nov; 78(5):471-7. PubMed ID: 20412115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The MEF2C gene-microdeletion 5q14.3 dilemma and three axioms for molecular syndromology.
    Wilson GN
    Am J Med Genet A; 2013 Apr; 161A(4):916-7. PubMed ID: 23495102
    [No Abstract]   [Full Text] [Related]  

  • 12. Microdeletion 5q14.3 and anomalies of brain development.
    Hotz A; Hellenbroich Y; Sperner J; Linder-Lucht M; Tacke U; Walter C; Caliebe A; Nagel I; Saunders DE; Wolff G; Martin P; Morris-Rosendahl DJ
    Am J Med Genet A; 2013 Sep; 161A(9):2124-33. PubMed ID: 23824879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An intellectually disabled patient with the 5q14.3q15 microdeletion syndrome associated with an apparently de novo t(2;5)(q13;q14).
    Toral-López J; Buentello-Volante B; Balderas-Minor MM; Amezcua-Herrera C; Valdes-Miranda JM; González-Huerta LM; Gudiño M; Cuevas-Covarrubias SA; Zenteno JC
    Am J Med Genet A; 2012 Apr; 158A(4):942-6. PubMed ID: 22419405
    [No Abstract]   [Full Text] [Related]  

  • 14. Late-onset gain of skills and peculiar jugular pit in an 11-year-old girl with 5q14.3 microdeletion including MEF2C.
    Berland S; Houge G
    Clin Dysmorphol; 2010 Oct; 19(4):222-224. PubMed ID: 20729728
    [No Abstract]   [Full Text] [Related]  

  • 15. RASA1 somatic mutation and variable expressivity in capillary malformation/arteriovenous malformation (CM/AVM) syndrome.
    Macmurdo CF; Wooderchak-Donahue W; Bayrak-Toydemir P; Le J; Wallenstein MB; Milla C; Teng JM; Bernstein JA; Stevenson DA
    Am J Med Genet A; 2016 Jun; 170(6):1450-4. PubMed ID: 26969842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expanding the clinical and molecular findings in RASA1 capillary malformation-arteriovenous malformation.
    Wooderchak-Donahue WL; Johnson P; McDonald J; Blei F; Berenstein A; Sorscher M; Mayer J; Scheuerle AE; Lewis T; Grimmer JF; Richter GT; Steeves MA; Lin AE; Stevenson DA; Bayrak-Toydemir P
    Eur J Hum Genet; 2018 Oct; 26(10):1521-1536. PubMed ID: 29891884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroendocrine phenotypes in a boy with 5q14 deletion syndrome implicate the regulatory roles of myocyte-specific enhancer factor 2C in the postnatal hypothalamus.
    Sakai Y; Ohkubo K; Matsushita Y; Akamine S; Ishizaki Y; Torisu H; Ihara K; Sanefuji M; Kim MS; Lee KU; Shaw CA; Lim J; Nakabeppu Y; Hara T
    Eur J Med Genet; 2013 Sep; 56(9):475-83. PubMed ID: 23832106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ADGRV1 is implicated in myoclonic epilepsy.
    Myers KA; Nasioulas S; Boys A; McMahon JM; Slater H; Lockhart P; Sart DD; Scheffer IE
    Epilepsia; 2018 Feb; 59(2):381-388. PubMed ID: 29266188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical phenotype and genetic analysis of a case of 5q14.3 microdeletion syndrome].
    Xu X; Li H; Zhang L; Lu F; Tang J
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2021 Nov; 38(11):1127-1131. PubMed ID: 34729758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prenatal detection of 5q14.3 duplication including MEF2C and brain phenotype.
    Cesaretti C; Spaccini L; Righini A; Parazzini C; Conte G; Crosti F; Redaelli S; Bulfamante G; Avagliano L; Rustico M
    Am J Med Genet A; 2016 May; 170A(5):1352-7. PubMed ID: 26864752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.